{
    "clinical_study": {
        "@rank": "114432", 
        "acronym": "Break-1", 
        "arm_group": {
            "arm_group_label": "Advanced cancer patients with pain"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to describe how often advanced cancer patients experience\n      breakthrough pain (BTcP), and to describe how this pain is treated, and how effective these\n      treatments are."
        }, 
        "brief_title": "Observational Study of Incidence of Breakthrough Cancer Pain and How it is Treated", 
        "completion_date": {
            "#text": "September 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Advanced Cancer", 
        "condition_browse": {
            "mesh_term": "Neoplasms"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Diagnosis of neoplasm in advanced stage\n\n          -  Chronic pain controlled for at least one week with opioids 60 mg / day morphine\n             equivalent\n\n          -  1-6 episodes of BTcP within any of 3 days previous to registration into study\n\n          -  Signed Informed Consent\n\n        Exclusion Criteria:\n\n        \u00b7 More than 6 episodes of BTcP within any of 3 days previous to registration into study"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients with advanced cancer and chronic pain being controlled with opiods."
            }
        }, 
        "enrollment": {
            "#text": "500", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 20, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02069067", 
            "org_study_id": "Break-1"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "breakthrough cancer pain", 
            "pain", 
            "neuropathic pain", 
            "intractable pain", 
            "cancer"
        ], 
        "lastchanged_date": "February 20, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Castellammare di Stabia", 
                        "country": "Italy"
                    }, 
                    "name": "Ospedale San Leonardo"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Napoli", 
                        "country": "Italy"
                    }, 
                    "name": "Istituto Nazionale dei Tumori , Unita Terapia Antalgica"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nola", 
                        "country": "Italy"
                    }, 
                    "name": "S. Maria della Piet\u00e0"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Italy"
        }, 
        "number_of_groups": "1", 
        "official_title": "Multicenter Observational Study of the Incidence and Treatment Modalities of Breakthrough Cancer Pain in Patients With Chronic Cancer Pain", 
        "overall_contact": {
            "email": "francesco.perrone@usc-intnapoli.net", 
            "last_name": "Francesco Perrone, M.D., Ph.D.", 
            "phone": "+390815903571"
        }, 
        "overall_contact_backup": {
            "email": "marina.piccirillo@usc-intnapoli.lnet", 
            "last_name": "Maria Carmela Piccirillo, M.D.", 
            "phone": "+390815903631"
        }, 
        "overall_official": [
            {
                "affiliation": "NCI Naples, Division of Pain Therapy", 
                "last_name": "Arturo Cuomo, M.D.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "NCI Naples, Clinical Trials Unit", 
                "last_name": "Francesco Perrone, M.D., Ph.D.", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Italy: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "number of patients who experience BTcP", 
                "safety_issue": "No", 
                "time_frame": "one year"
            }, 
            {
                "measure": "treatments used to treat BTcP", 
                "safety_issue": "No", 
                "time_frame": "one year"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02069067"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "evaluate the relationship between pain intensity, patient characteristics, and clinician choice of pain medication", 
                "measure": "pain intensity", 
                "safety_issue": "No", 
                "time_frame": "4 weeks"
            }, 
            {
                "measure": "time to pain relief of BTcP", 
                "safety_issue": "No", 
                "time_frame": "4 weeks"
            }, 
            {
                "description": "to verify a correlation between initial dose for BTcP and daily dose of baseline pain therapy", 
                "measure": "initial dose of therapy (in morphine equivalents) for BTcP", 
                "safety_issue": "No", 
                "time_frame": "4 weeks"
            }, 
            {
                "description": "to verify a correlation between effective dose for BTcP and daily dose of baseline pain therapy  (dose reported in morphine equivalents)", 
                "measure": "effective dose for BTcP", 
                "safety_issue": "No", 
                "time_frame": "4 weeks"
            }
        ], 
        "source": "National Cancer Institute, Naples", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "National Cancer Institute, Naples", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2011", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "February 2014"
    }
}